Accéder au contenu
Merck

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.

Bioinorganic chemistry and applications (2015-09-09)
Simone Rodrigues Silva, Érica Correia Duarte, Guilherme Santos Ramos, Flávio Vinícius Crizóstomo Kock, Fabiana Diuk Andrade, Frédéric Frézard, Luiz Alberto Colnago, Cynthia Demicheli
RÉSUMÉ

Complexes of gadolinium(III) with N-octanoyl-N-methylglucamine (L8) and N-decanoyl-N-methylglucamine (L10) with 1 : 2 stoichiometry were synthesized and characterized by elemental analysis, electrospray ionization-tandem mass spectrometry (ESI-MS), infrared (IR) spectroscopy, and molar conductivity measurements. The transverse (r 2) and longitudinal (r 1) relaxivity protons were measured at 20 MHz and compared with those of the commercial contrasts. These complexes were incorporated in liposomes, resulting in the increase of the vesicle zeta potential. Both the free and liposome-incorporated gadolinium complexes showed high relaxation effectiveness, compared to commercial contrast agent gadopentetate dimeglumine (Magnevist). The high relaxivity of these complexes was attributed to the molecular rotation that occurs more slowly, because of the elevated molecular weight and incorporation in liposomes. The results establish that these paramagnetic complexes are highly potent contrast agents, making them excellent candidates for various applications in molecular MR imaging.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1,6-Diphenyl-1,3,5-hexatriene, 98%
Sigma-Aldrich
Gadolinium(III) chloride hexahydrate, 99% (titration)
Sigma-Aldrich
Gadolinium(III) chloride hexahydrate, 99.999% trace metals basis
Sigma-Aldrich
N-Decanoyl-N-methylglucamine, ≥98% (GC)
Sigma-Aldrich
N-Octanoyl-N-methylglucamine, ≥97% (GC)